PSMA-PET with 18F-PSMA approved in Switzerland since October 2019. Compared to choline PET, PSMA PET has a significantly higher sensitivity for lymph node and distant metastases and, unlike choline PET, can also be used for the initial clarification / staging of prostate cancer.
The coronary MIP image in this 67-year-old patient provides an initial overview. After a radical prostate resection in 2013, the PSA rose again to currently 0.22 ng/ml. On the axial fused images, a focal PSMA accumulation can be detected in a pararectal lymph node with a diameter of only 3 mm (yellow arrow). Despite its small size, this is therefore suspicious of a lymph node metastasis.
The following indication is covered by health insurance:
Senior Physician, Vice Director of Department, Department of Nuclear Medicine
Attending Physician, Department of Nuclear Medicine
Senior Attending Physician, Department of Nuclear Medicine
Senior Attending Physician, Department of Nuclear Medicine
Senior Attending Physician, Department of Nuclear Medicine
As a patient, you cannot register directly for a consultation. Please get a referral from your primary care physician, specialist. For questions please use our contact form.
Simply assign your patient via registration form.
Medical information hotline: 08.00-18.00 hrs: +41 44 255 15 02